Literature DB >> 4951632

Fibrinolysis.

G R Fearnley.   

Abstract

Mesh：

Substances：

Year:  1967        PMID： 4951632      PMCID： PMC2311988     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN： 0035-8843            Impact factor:   1.891


× No keyword cloud information.
  4 in total

1.  Origin of blood fibrinolytic activity from veins and its bearing on the fate of venous thrombi.

Authors:  R CHAKRABARTI; P M BIRKS; G R FEARNLEY
Journal:  Lancet       Date:  1963-06-15       Impact factor: 79.321

2.  The histological localisation of fibrinolysin activator.

Authors:  A S TODD
Journal:  J Pathol Bacteriol       Date:  1959-07

3.  Induction of fibrinolysis by venous obstruction.

Authors:  R L CLARKE; A ORANDI; E E CLIFFTON
Journal:  Angiology       Date:  1960-10       Impact factor: 3.619

4.  Fibrinolysis in pulmonary vascular disease.

Authors:  R C Ellison; J Brown
Journal:  Lancet       Date:  1965-04-10       Impact factor: 79.321
  4 in total
  5 in total

1.  Plasma is the physiologic buffer of tissue plasminogen activator-mediated fibrinolysis: rationale for plasma-first resuscitation after life-threatening hemorrhage.

Authors:  Hunter B Moore; Ernest E Moore; Eduardo Gonzalez; Gregory Wiener; Michael P Chapman; Monika Dzieciatkowska; Angela Sauaia; Anirban Banerjee; Kirk C Hansen; Christopher Silliman
Journal:  J Am Coll Surg       Date:  2015-03-31       Impact factor: 6.113

2.  Acute Fibrinolysis Shutdown after Injury Occurs Frequently and Increases Mortality: A Multicenter Evaluation of 2,540 Severely Injured Patients.

Authors:  Hunter B Moore; Ernest E Moore; Ioannis N Liras; Eduardo Gonzalez; John A Harvin; John B Holcomb; Angela Sauaia; Bryan A Cotton
Journal:  J Am Coll Surg       Date:  2016-01-22       Impact factor: 6.113

3.  Hemoglobin-based oxygen carriers promote systemic hyperfibrinolysis that is both dependent and independent of plasmin.

Authors:  Alexander P Morton; Ernest E Moore; Hunter B Moore; Eduardo Gonzalez; Michael P Chapman; Erik Peltz; Anirban Banerjee; Christopher Silliman
Journal:  J Surg Res       Date:  2015-04-25       Impact factor: 2.192

4.  Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy.

Authors:  Hunter B Moore; Ernest E Moore; Eduardo Gonzalez; Michael P Chapman; Theresa L Chin; Christopher C Silliman; Anirban Banerjee; Angela Sauaia
Journal:  J Trauma Acute Care Surg       Date:  2014-12       Impact factor: 3.313

5.  Hemolysis exacerbates hyperfibrinolysis, whereas platelolysis shuts down fibrinolysis: evolving concepts of the spectrum of fibrinolysis in response to severe injury.

Authors:  Hunter B Moore; Ernest E Moore; Eduardo Gonzalez; Kirk C Hansen; Monika Dzieciatkowska; Michael P Chapman; Angela Sauaia; Bernadette West; Anirban Banerjee; Christopher C Silliman
Journal:  Shock       Date:  2015-01       Impact factor: 3.454
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.